Theoretically, anyone can say anything they want to anyone they want. From a sales rep perspective, they are bound by a fair amount of confidentiality and insider agreements. They should not be telling friends and family information that is not readily available to the general public as released by the company. There again, anyone can say what they want, but who would they be telling? The media? Brokerage houses?
Of course I hope sale are exceeding expectations, but who knows the reason for the increase...short covering? Greater confidence in the company? Sales better than expected? EU Partnership? No 180 day questions related to the EU regulatory submission? Just as long as it keeps increasing, I do not care actually! Keep it trending higher!
Indeed for a change. Funny how what ordinarily would be viewed as positive events can't seem to move this stock, but potential inside information may be doing it....not that the system is corrupt or anything like that. But hey, who cares as long as it is going up!
Nice...where did you make that up....I mean see that? Lol. I hope you have something to back that up since you provided so much to support the statement.
Crazy isn't it...I think it may be a result of what appears to be a very low float suggesting that there are not a lot of shares out there to trade. Also with the market it is on does not help. Although, I am not sure of how the bid and ask prices are set. This is where you have to set a limit price when doing transactions. The one positive may be that if there is some good news released and a fair amount of interest in buying, we could see quite the spike in price. I still recall when the price of this was 8 bucks a share...Would totally love to see it again!
Nothing for weeks and then explosive action lol. I hope it is a preview of things to come...perhaps decent earnings coming up...should be reported soon. Back to $3 would be nice; although, I would be happy with 50 cents!
I will say first full quarter of sales is 3 to 6 million; annualized that is 12 to 24 million, which is probably accurate for the first year of introduction. The trending of the stock price is not suggesting any more. When they throw out the term "market" or "market potential" it assumes sales if you have the full market and everyone using the product. If you capture 10% of that in the first year you are doing well is seems. Time will tell.
Small number of shares trading, but appears to be trending in the right direction. Hopefully loosening up on the online gaming in the states is giving this some visibility. Time will tell.
Looks like something is happening, but that would suggest some inside information leaked out before it was announced to the general public, and we know that is not allowed or ever happens. I think the 15 % increase and large volume is purely coincidental...what else could it be. Lol
These are very seldom good, and typically the stock price will decay over time due to the lack of change in business fundamentals. Not sure why anyone would expect otherwise. The only difference is that the stock has more room to fall. I can think of maybe one or two companies that eventually did okay post RS
Makes you wonder, and we will most probably never know. The total number of issued shares looks higher than I remember, so who knows; they could be issuing shares whenever they feel like it. The post-Kumar leadership will surely take good care of the share holders no doubt...yeah, right! I am not sure what will get the share price moving.
Oh never saw any information on the FDA website either... I will have to check out the oldtimers board as suggested by a previous post.
Oh you mean like the citizen's petition that was submitted to FDA about two years ago to look out for the well being of humanity higlighting all of the risks associated with Lymphoseek? Well, also coincidently, the idea that the person who submitted it just so happen to take a large short position just before he did so. Purely coincidental I am sure... I wonder what ever happened with it.
It makes you wonder what milestones, progress, or news is required to move the share price...well up that is. Clearly the conferences/symposiums do not do it and never really have. There are enough upcoming key events that should have individual or collective impact...hopefully positive news brings the increase. Let's see...potential EU partnership, EU approval, Launch of Lymphoseek, at a minimum. Time will tell. Not sure why anyone who has been in this for an extended period would get out now. Of course there is something to be said for getting back to even or taking some profits.
I did not know the SEC could do that. What companies has the SEC exercised that option in the past? I had never heard of it happening before, not that that means anything!
Well, it looks like the recent presentation did not move the stock price at all, but can't say I expected it to.
Not disagreeing by any means. I think the business model is robust and focused on key diseases. I just see do not see a lot of unknowns being revealed at these conferences. Perhaps data summaries in support of the efficacy arguments as well as highlighting the benefits over currently used products. There again, I can't imagine that a partner would be announced or anything that we do not already know, but rather having it packaged together for a single presentation.
What is expected to be said other than what already has been? I am not sure if these forums are used for major anouncements or unvailing new clinical data. I guess perhaps an update on a EU partner could be given or something on the EU filing. Perhaps another comment about the lack of progress around RIGS. My guess will be that the price drops as there is so much expectation around "news" at these conferences, but then when they fail to deliver, then the stocks drop. I would imagine all the news at this point in time is out, and at most there might be a summary. Of course I hope I am wrong and a huge partnership for the EU is announced, additional products will be added to the portfolio, and the stock goes up a buck a share. I just do not see it stemming from this conference.
You mean word is not out yet? What information would you expect to come out during this presentation. I hope it is not like ASCO from a few years back as that was the beginning of the decline in stock price off its highs in fives. ASCO seemed to provided the forum for everyone to jump on the wagon as to why Lymphoseek is not good, and even with all the postivie news, it did not recover anywhere near the high.